Home Blog Childhood Epilepsy
  1. Epilepsy Gets New Clinical Definition

    Epilepsy Gets New Clinical Definition

    A new clinical definition for epilepsy has been created by a task force of epilepsy experts, with the aim of “refining the scope” of patients diagnosed with the disease. In 2005, the International League Against Epilepsy (ILAE) task force authored a report offering a definition of epilepsy as “a disorder of the...

    read more

  2. Sunovion’s once-daily epilepsy drug Aptiom debuts in US

    Sunovion’s once-daily epilepsy drug Aptiom debuts in US

    USA-based Sunovion Pharmaceuticals, a subsidiary of Japanese drug major Dainippon Sumitomo (TYO: 4506), has launched its Aptiom (eslicarbazepine acetate), a once-daily antiepileptic drug (AED) indicated for use as adjunctive treatment of partial-onset seizures, is now available by prescription in pharmacies across the USA. Aptiom, a voltage-gated sodium channel blocker, is...

    read more

  3. Researchers use ultrasound to destroy cancerous tissue in brain

    Researchers use ultrasound to destroy cancerous tissue in brain

    Researchers in Zurich, Switzerland have successfully used focused ultrasound for the first time to non-invasively ablate part of a recurrent glioma tumor through a patient’s intact skull. The procedure was performed to assess the feasibility and safety of focused ultrasound in treating brain tumors; it was not intended to demonstrateefficacy. The procedure was conducted using...

    read more

  4. Your Brain on Alcohol, and AutoImmune Epilepsy

    Your Brain on Alcohol, and AutoImmune Epilepsy

    Molecular analysis of brain tissue from alcoholics revealed numerous differences from normal controls, potentially providing a key link connecting the brain to behavior in chronic alcoholism. Also, another study connects autoimmunity to at least some cases of epilepsy, and a novel antipsychotic drug targets negative symptoms in schizophrenia. This Is...

    read more

  5. Harvard stem cell scientists discover potential treatment for amyotrophic lateral sclerosis

    Harvard stem cell scientists discover potential treatment for amyotrophic lateral sclerosis

    Discovery will lead directly to clinical trials Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig’s disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the...

    read more